HIV and lacaziosis, Brazil [7]

Emerging Infectious Diseases

Volumn 12, Issue 3, 2006, Pages 526-527

  Xavier, Marilia B ^a   Ferreira, Marcia M R ^a   Quaresma, Juarez A S ^a   De Brito, Arival C ^a  

^a Para Federal University   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CLOFAZIMINE;

ADULT; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION SENSITIVITY; LACAZIOSIS; LETTER; MALE; MYCOSIS; RECURRENT DISEASE; SEROLOGY; SKIN BIOPSY;

EID: 33644504868     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1203.051426     Document Type: Letter

References (7)

1. Restrepo A. Treatment of tropical mycosis. J Am Acad Dermatol. 1994;31:S91-102.
2. Taborda PR, Tabora VA, McGinnis MR. Lacazia loboi gen. nov., comb. nov., the etiologic agent of lobomycosis. J Clin Microbiol. 1999;37:2031-3.
3. Kwon-Chung C. Phylogenetics of fungi that are pathogenic to humans. Clin Infect Dis. 1994;19:S1-7.
4. Haubold EM, Aronson JF, Cowwan DF. Isolation of fungal rDNA from bottlenose dolphin skin infected with Loboa loboi. Med Mycol. 1998;36:263-7.
5. Funchs J, Milbradt R, Pecher SA, Lobomycosis (keloidal blastomycosis): case reports and overview. Cutis. 1990;46:227-34.
6. Elsayed S, Kuhn SM, Barber D, Church DL, Adams S, Kasper R. Human case of lobomycosis. Emerg Infect Dis. 2004;10:715-18.
7. Pecher SA, Funchs J. Cellular immunity in lobomycosis (keliodal blastomycosis). Allergol Immunopathol (Madr). 1988;16:413-5.